Perfil
Harald Poth is currently the Chairman-Supervisory Board at Phenex Pharmaceuticals AG, Director at Acousia Therapeutics GmbH, and Senior Investment Manager at LBBW Venture Capital GmbH.
He holds a doctorate degree from the University of Hohenheim.
Cargos activos de Harald Poth
| Empresas | Cargo | Inicio |
|---|---|---|
LBBW Venture Capital GmbH
LBBW Venture Capital GmbH Investment ManagersFinance LBBW Venture Capital invests in companies located in DACH region. The firm targets companies operating in the fields of disruptive information technology, life sciences, software, digital formation and fintech. It provides financing for seed and early stage capital requirements with an investment size up to EUR 3 million. | Inversor de Capital Privado | - |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Specializes in identification and analysis of selective drug candidates for nuclear receptors using its SNuRM technology | Presidente | - |
Acousia Therapeutics GmbH
Acousia Therapeutics GmbH BiotechnologyHealth Technology Develops drugs for local application | Director/Miembro de la Junta | - |
Formación de Harald Poth.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
LBBW Venture Capital GmbH
LBBW Venture Capital GmbH Investment ManagersFinance LBBW Venture Capital invests in companies located in DACH region. The firm targets companies operating in the fields of disruptive information technology, life sciences, software, digital formation and fintech. It provides financing for seed and early stage capital requirements with an investment size up to EUR 3 million. | Finance |
University of Hohenheim
University of Hohenheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Specializes in identification and analysis of selective drug candidates for nuclear receptors using its SNuRM technology | Health Technology |
Acousia Therapeutics GmbH
Acousia Therapeutics GmbH BiotechnologyHealth Technology Develops drugs for local application | Health Technology |
- Bolsa de valores
- Insiders
- Harald Poth
















